Digestive Health

Two healthy beverage newcomers are turning heads-with barley and pickle.

Researchers found that patented probiotic Ganeden BC30 was able to survive the manufacturing and preparation of pasta without affecting the characteristics of the pasta.

The supplements industry is surviving-even thriving-in a difficult year.

Ever multifunctional, fiber has found its sweet spot.

A new study suggests fucoidan may be effective at dislodging bacteria that causes chronic stomach inflammation, peptic ulcer diseases, and gastric cancers.

Relizorb, a “first-of-its kind digestive enzyme cartridge designed to mimic the normal pancreatic function,” recently received FDA approval.

“The conflict between a high iron requirement and the risk of side effects when using high doses of iron supplement can only be solved in one way-by improving the iron uptake," says Probi AB.

A look back at some of the year’s most impactful research on dietary supplement ingredients.

An upcoming study will explore how brain changes affect the gut microbiome in patients with irritable bowel syndrome.

A new study offers the “largest dataset ever published from a randomized, placebo-controlled study on the effect of probiotics on bowel function,” says Chr. Hansen.

Fruit d’Or Nutraceuticals announces two new launches and a new cranberry dossier.

Bayer’s FTC legal battle triumph underscores the rightful difference between dietary supplements and drugs.

A soon-to-be published study suggests ibSium may reduce abdominal pain and discomfort in people suffering from IBS.

Mental and hormonal health may be the future of the probiotics market, but is the research there yet?

Step aside, pre- and probiotics. There is another chapter to the digestive-health story called “plusbiotics,” says GCI Nutrients.

DSM calls Tolerase G “the first and the only digestive enzyme demonstrated to effectively break down residual gluten in the stomach.”

Lesaffre has licensed ibSium exclusively in Canada to a company called Medical Futures Inc., which plans to launch an IBS product in the near future.

Ray Matulka, PhD, director of toxicology for the Burdock Group, will discuss the regulatory boundaries for probiotics as supplements and foods in the United States.

Probiotics Workshop guest speaker Sunita Kumar gave us a birds’-eye view of what we can expect from the emerging microbiome sphere moving forward.

Pharmachem is sponsoring a seminar to discuss the benefits of its Microbac technology and probiotic research on new health areas.

A new study out of Tasmania suggests the seaweed extract may have potential to alleviate ulcerative colitis.

Are enzymes derived from gluten-containing sources truly gluten-free?

High-protein products are only as effective as the enzymes that optimize them.

A new study suggests gold and green kiwifruit supplements may promote bowel health in healthy people.

Probiotics turn to new marketing platforms.